News Channels

30 Aug 2018 Poxel Expands Metabolic Pipeline Through Strategic Acquisition Agreement with DeuteRx for DRX-065, a Novel Clinical Stage Drug Candidate for NASH, and Other Programs
30 Aug 2018 Arena Pharmaceuticals Presented Phase 1 Clinical Data for Ralinepag in Pulmonary Arterial Hypertension at the European Society of Cardiology
30 Aug 2018 Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines
30 Aug 2018 European Commission approves new easy-to-use, once-weekly Bydureon BCise device for patients with type-2 diabetes
30 Aug 2018 Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration
30 Aug 2018 SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia
29 Aug 2018 Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia
29 Aug 2018 ProLynx and Daiichi Sankyo announce the development of technology for half-life extension of small molecules in the eye
29 Aug 2018 European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
29 Aug 2018 Duzallo, a fixed-dose combination therapy for gout, approved in Europe
29 Aug 2018 Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2
29 Aug 2018 Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder
29 Aug 2018 TARIS Announces Positive Topline Data for TAR-302 in Patients with Idiopathic Overactive Bladder
29 Aug 2018 First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
29 Aug 2018 Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab
29 Aug 2018 Theratechnologies Files Marketing Authorization Application for Trogarzo™ in Europe
29 Aug 2018 Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
29 Aug 2018 Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma
29 Aug 2018 European Commission approves Novartis combination therapy Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600 mutation-positive melanoma
29 Aug 2018 Xenon Announces Positive XEN1101 Pharmacodynamic Data from Phase 1b TMS Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top